For more information regarding the October 24 - 29, 2008 American College of Rheumatology meeting in San Francisco, CA please visit the official ACR meeting site at this link: http://www.rheumatology.org/annual/08meeting.asp

CCP Abstracts from the 2007 ACR Meeting November 2007; Boston, MA.

• Two Novel Assays-Third Generation Cyclic Citrullinated Peptides and Antibodies Against Modified Citrullinated Vimentin in the Diagnosis of Rheumatoid Arthritis and Relation with Disease Activity
• The Inova CCP3.1 IgA/IgG ELISA Represents Significant Improvement in the Laboratory Diagnosis of Rheumatoid Arthritis
• Rheumatoid Arthritis Diagnosis: A Comparative Study of Second and Third Generation Anti-Cyclic Citrullinated Peptide (CCP) Antibody Elisas
• Reactivity of Antibodies to Cyclic Citrullinated Peptide (CCP) and Unmodified Arginine Peptide in SLE as a Marker of Destructive/Deforming Arthritis
• Measurement of Biomarkers in Juvenile Idiopathic Arthritis Patients and Their Significant Association with Disease Severity: A Comparative Study
• The T Allele of the PTPN22 1858C/T Polymorphism is Associated with Markers of Increased Disease Severity in Rheumatoid Arthritis
• Anti-Cyclic Citrullinated Peptide Antibody Isotypes in Rheumatoid Arthritis: Association with Disease Duration, Rheumatoid Factor Production and the Presence of Shared Epitope
• Anti-CCP-Modified Criteria for the Classification of Early Rheumatoid Arthritis